Novartis Ag (NVS) Net Debt Issuances and Repayments (2009 - 2024)
Novartis Ag (NVS) posted Net Debt Issuances and Repayments of -$382.0 million for Q3 2024, up 88.06% sequentially from -$3.2 billion in Q2 2024, and up 54.09% YoY from -$247.9 million in Q4 2023.
Novartis Ag (NVS) Net Debt Issuances and Repayments (2009 - 2024) Analysis & Trends
Novartis Ag (NVS) has 5 years of Net Debt Issuances and Repayments data on file, last reported at -$382.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Debt Issuance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | - |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | - |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | - |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 1.57 Bn |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | - |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | - |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | - |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -382.00 Mn |
| Sep 30, 2024 | -382.00 Mn |
| Jun 30, 2024 | -3.20 Bn |
| Jun 30, 2024 | -3.20 Bn |
| Dec 31, 2023 | -607.00 Mn |
| Dec 31, 2023 | -607.00 Mn |
| Sep 30, 2023 | -832.00 Mn |
| Sep 30, 2023 | -832.00 Mn |
| Jun 30, 2023 | -3.64 Bn |
| Jun 30, 2023 | -3.64 Bn |
| Jun 30, 2019 | -28.00 Mn |
| Jun 30, 2019 | -28.00 Mn |
| Jun 30, 2018 | -1.53 Bn |
| Jun 30, 2018 | -1.53 Bn |
| Dec 31, 2009 | -141.00 |
| Dec 31, 2009 | -141.00 |